We are live on ! Find out more
VERV

Verve Therapeutics
VERV

Delisted

VERV was delisted on the 24th of July, 2025.

Back to rankings

6 hedge funds and large institutions have $1.24M invested in Verve Therapeutics in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 169 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

81.59% less ownership

Funds ownership: 81.84% → 0.26% (-82%)

97% less funds holding

Funds holding: 175 → 6 (-169)

100% less capital invested

Capital invested by funds: $819M → $1.24M (-$818M)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 169

Holders
6
Holders Change
-169
Holders Change %
-96.57%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
169
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$955K
2
IA
IFP Advisors
Florida
+$4.29K

Top Sellers

Rank Fund Capital Flow
1
AI
Alphabet Inc
California
-$137M
2
BlackRock
BlackRock
New York
-$82.6M
3
PCM
Pentwater Capital Management
Florida
-$75.5M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$47.1M
5
CC
Casdin Capital
New York
-$46M
Name Holding Trade Value Shares
Change 		Change in
Stake
SPS
126
Susquehanna Portfolio Strategies
Pennsylvania
– -$149K -13,300 Closed
SPA
127
Sherbrooke Park Advisers
New York
– -$148K -13,215 Closed
SOW
128
State of Wyoming
Wyoming
– -$145K -12,937 Closed
New York State Common Retirement Fund
129
New York State Common Retirement Fund
New York
– -$144K -12,855 Closed
DFCM
130
Dark Forest Capital Management
Puerto Rico
– -$142K -12,648 Closed
LPL Financial
131
LPL Financial
California
– -$141K -12,597 Closed
KPWS
132
Kestra Private Wealth Services
Texas
– -$135K -12,000 Closed
SA
133
Sanctuary Advisors
Indiana
– -$131K -11,665 Closed
CAM
134
Clark Asset Management
New Hampshire
– -$129K -11,494 Closed
D.E. Shaw & Co
135
D.E. Shaw & Co
New York
– -$119K -10,586 Closed
KK
136
KLP Kapitalforvaltning
Norway
– -$115K -10,200 Closed
HW
137
Hamilton Wealth
California
– -$112K -10,000 Closed
PCM
138
PenderFund Capital Management
British Columbia, Canada
– -$98.8K -8,800 Closed
TRCT
139
Tower Research Capital (TRC)
New York
– -$98.5K -8,773 Closed
Fidelity Investments
140
Fidelity Investments
Massachusetts
– -$90K -8,015 Closed
Zurich Cantonal Bank
141
Zurich Cantonal Bank
Switzerland
– -$89.5K -7,973 Closed
Nisa Investment Advisors
142
Nisa Investment Advisors
Missouri
– -$84.1K -7,485 Closed
AIP
143
Ameritas Investment Partners
Nebraska
– -$73.8K -6,570 Closed
Raymond James Financial
144
Raymond James Financial
Florida
– -$70.6K -6,288 Closed
SAM
145
Shell Asset Management
Netherlands
– -$65K -5,806 Closed
EPM
146
Equitec Proprietary Markets
Illinois
– -$55K -4,900 Closed
AF
147
Allworth Financial
California
– -$51K -4,545 Closed
Mirae Asset Global Investments
148
Mirae Asset Global Investments
South Korea
– -$38.7K -3,444 Closed
Federated Hermes
149
Federated Hermes
Pennsylvania
– -$29.7K -2,645 Closed
FFA
150
Farther Finance Advisors
California
– -$27.8K -2,477 Closed
3 4 5
6
7

VERV Hedge Fund Activity: Q3 2025 in Review

6 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Verve Therapeutics (VERV) for Q3 2025, worth a combined $1.24M — down 100% from $819M a quarter earlier.

Sellers outnumbered buyers: 169 funds closed out of VERV and 0 opened new positions — a net loss of 169 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was XTX Topco, adding an estimated $955K. The largest seller was Alphabet Inc, exiting entirely with an estimated $137M sold.

  • 6 institutional investors held Verve Therapeutics (VERV) as of Q3 2025, down from 175 in Q2 2025.
  • Funds reported $1.24M of Verve Therapeutics stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Verve Therapeutics positions in Q3 2025 and 169 closed out, a net change of -169 holders.
  • The largest Verve Therapeutics buyer in Q3 2025 was XTX Topco, an estimated $955K added.
  • The largest Verve Therapeutics seller in Q3 2025 was Alphabet Inc, an estimated $137M sold.

Based on aggregated 13F filings for Q3 2025.